Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Randomized clinical trials of treatment options for in-stent restenosis. The lowest angiographic restenosis rates reported to date are for drug-eluting stents as a treatment of in-stent restenosis. ARTIST (9) = Angioplasty Versus Rotational Atherectomy for Treatment of Diffuse In-Stent Restenosis Trial; BMS = bare metal stent; ISAR-DESIRE (19) = Intracoronary Stenting with Antithrombotic Regimen–Drug-Eluting Stents for In-Stent Restenosis; PES = paclitaxel-eluting stent; RESCUT (10) = Restenosis Cutting Balloon Evaluation Trial; RIBS-I (11) = Restenosis Intrastent: Balloon Angioplasty Versus Elective Bare Metal Stenting; RIBS II (18) = Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting; SES = sirolimus-eluting stent; START (15) = Sr90 Treatment of Angiographic Restenosis; WRIST (12) = Washington Radiation for In-Stent Restenosis Trial.
|
